BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 312696)

  • 1. Current concepts in immunoregulatory T-cell neoplasms.
    Broder S; Uchiyama T; Waldmann TA
    Cancer Treat Rep; 1979 Apr; 63(4):607-12. PubMed ID: 312696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neoplasms of immunoregulatory cells.
    Broder S; Uchiyama T; Waldmann TA
    Am J Clin Pathol; 1979 Oct; 72(4 Suppl):724-31. PubMed ID: 158979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Normal and malignant T cells in the regulation of inflammation and immunity.
    Broder S
    Agents Actions Suppl; 1980; 7():134-42. PubMed ID: 6454333
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the humoral immune response: from immunoglobulin genes to regulatory T cell networks.
    Waldmann TA; Korsmeyer SJ; Hieter PA; Ravetch JV; Broder S; Leder P
    Fed Proc; 1983 May; 42(8):2498-503. PubMed ID: 6404657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoplasms of immunoregulatory T cells in clinical investigation.
    Broder S; Muul L; Marshall S; Waldmann TA
    J Invest Dermatol; 1980 May; 74(5):267-71. PubMed ID: 6967093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells.
    Broder S; Poplack D; Whang-Peng J; Durm M; Goldman C; Muul L; Waldmann TA
    N Engl J Med; 1978 Jan; 298(2):66-72. PubMed ID: 304175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of leukemic pro-suppressor cells to become suppressor-effector cells. Influence of cooperating normal T cells.
    Broder S; Uchiyama T; Muul LM; Goldman C; Sharrow S; Poplack DG; Waldmann TA
    N Engl J Med; 1981 Jun; 304(23):1382-7. PubMed ID: 6453293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypogammaglobulinaemia associated with abnormalities of both B and T lymphocytes in patients with chronic lymphatic leukaemia.
    Hersey P; Wotherspoon J; Reid G; Gunz FW
    Clin Exp Immunol; 1980 Mar; 39(3):698-707. PubMed ID: 6445798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical significance of lymphocyte populations].
    Flad HD
    Med Klin; 1979 Aug; 74(34):1199-206. PubMed ID: 388169
    [No Abstract]   [Full Text] [Related]  

  • 10. Abnormalities of immunoregulatory cells in immunodeficiency disease and cancer.
    Broder S; Muul L; Megson M; Waldmann TA
    Prog Clin Biol Res; 1981; 58():93-120. PubMed ID: 6455670
    [No Abstract]   [Full Text] [Related]  

  • 11. Cell surface differentiation antigens of the malignant T cell in Sezary syndrome and mycosis fungoides.
    Haynes BF; Bunn P; Mann D; Thomas C; Eisenbarth GS; Minna J; Fauci AS
    J Clin Invest; 1981 Feb; 67(2):523-30. PubMed ID: 6970206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of suppressor cells in the pathogenesis of common variable hypogammaglobulinemia and the immunodeficiency associated with myeloma.
    Waldmann TA; Broder S; Krakauer R; MacDermott RP; Durm M; Goldman C; Meade B
    Fed Proc; 1976 Jul; 35(9):2067-72. PubMed ID: 1084293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [T-cell neoplasms with helper or suppressor activity].
    Rupniewska ZM
    Acta Haematol Pol; 1981; 12(1):53-61. PubMed ID: 6458988
    [No Abstract]   [Full Text] [Related]  

  • 14. Immunologic characterization and ultrastructural correlations for 125 cases of B- and T-cell leukemias: studies of chronic and acute lymphocytic, prolymphocytic, lymphosarcoma cell and hairy cell leukemia, Sézary's syndrome, and other lymphoid leukemias.
    Said JW; Pinkus GS
    Cancer; 1981 Dec; 48(12):2630-42. PubMed ID: 6975649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressor T cells in the pathogenesis of hypogammaglobulinemia associated with a thymoma.
    Waldmann TA; Broder S; Durm M; Blackman M; Krakauer R; Meade B
    Trans Assoc Am Physicians; 1975; 88():120-34. PubMed ID: 1083579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Membrane markers of lymphoid cells in immunoproliferative diseases of man].
    Seligmann M; Brouet JC; Preud'homme JL
    Z Gesamte Inn Med; 1980 Jan; 35(2):66-9. PubMed ID: 6996351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. T cells in cutaneous lesions of Sézary syndrome and T-cell leukemia. Characterization by monoclonal antibodies.
    Buechner SA; Winkelmann RK; Banks PM
    Arch Dermatol; 1983 Nov; 119(11):895-900. PubMed ID: 6227293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunologic phenotyping of cutaneous lymphomas].
    Kaudewitz P; Burg G; Smolle J; Braun-Falco O
    Hautarzt; 1986 Dec; 37(12):647-55. PubMed ID: 2880828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cell differentiation and immunoregulatory T cell function in human cord blood lymphocytes.
    Tosato G; Magrath IT; Koski IR; Dooley NJ; Blaese RM
    J Clin Invest; 1980 Aug; 66(2):383-8. PubMed ID: 6249850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Studies of T- and B-cell interactions in adult patients with combined immunodeficiency.
    Morito T; Bankhurst AD; Williams RC
    J Clin Invest; 1980 Feb; 65(2):422-31. PubMed ID: 6444306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.